Pharma's Almanac | PCI Pharma Services

26 Articles Available

1 2

ESG

Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report

PR-M03-24-04

Commitment to ESG Principles

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

PAO-03-24-CL-03

Robotic Sterile Fill-Finish

Reducing Time to First-in-Human Trials with Robotic Sterile Fill-Finish Manufacturing Services

PAO-02-24-CL-03

Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

PAO-07-23-RT-01

Roundtable: Patient Centricity

How is an increased focus on patient-centric concerns influencing the way that you work?

PAO-07-23-RT-02

International Markets

In what international markets do you anticipate significant developments in the near future?

PAO-01-23-RT-02

Disruptive Technology

What do you view as the most disruptive or transformational technology or development on the horizon?

PAO-01-23-RT-01

Controlled Substances in Clinical Trials

Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand

PAO-01-23-CL-03

Robotic Sterile Fill-Finish

Accelerating Drug Development Using Robotic Sterile Fill-Finish Platforms

PAO-10-022-CL-09

Future of the Industry

What key indicators do you look at to predict the future of this industry?

PAO-10-022--RT-02

Sustainability

What is your plan to build a more sustainable business practice in the coming years?

PAO-10-022--RT-01

Unmet Needs

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

PAO-06-022--RT-01

Industry Challenges

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

O-06-022--RT-01

Capacity Expansion

PCI Pharma Services Announces Major Manufacturing Expansion with $100 Million Investment in New England, Providing Global Capacity to Clients

PR-M05-22-05

Leadership

Q: What’s the key to being a leader in the industry?

PAO-03-022-RT-02

Milestones

Q: What important company milestone do you anticipate reaching in 2022?

PAO-03-022-RT-01

Personalized and Precision Medicine

Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?

PAO-12-21-RT-01

Therapeutic Progress

Q: For what therapeutic area do you think we will see the greatest progress in the coming years?

PAO-12-21-RT-02

Biologics

An Evolving Biologics Landscape and Driving Innovation and Opportunity

PAO-11-21-CL-16

Oncology Clinical Trials

Delivering the Full Value Chain for Oncology Clinical Trials

PAO-07-21-CL-09

Digital Transformation

Seamlessly Sharing Supply Chain Information to Deliver Measurable Efficiencies for Clients

PAP-Q4-20-CL-020

M&A

Kohlberg and Mubadala Sign a Definitive Agreement to Acquire Majority Stake in PCI Pharma Services

PR-M08-20-NI-39

Digitization

The Power of Digital Transformation

PAP-Q2-20-CL-029

Packaging

Advanced, Flexible Packaging Solutions to Meet Parenteral Product Demand

PAP-Q4-19-CL-026

1 2

PCI Pharma Services

26 Articles Available

Can't find what you're looking for? Try our advanced search.

ESG

Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report

Commitment to ESG Principles

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

Robotic Sterile Fill-Finish

Reducing Time to First-in-Human Trials with Robotic Sterile Fill-Finish Manufacturing Services

Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

Roundtable: Patient Centricity

How is an increased focus on patient-centric concerns influencing the way that you work?

International Markets

In what international markets do you anticipate significant developments in the near future?

Disruptive Technology

What do you view as the most disruptive or transformational technology or development on the horizon?

Controlled Substances in Clinical Trials

Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand

Robotic Sterile Fill-Finish

Accelerating Drug Development Using Robotic Sterile Fill-Finish Platforms

Future of the Industry

What key indicators do you look at to predict the future of this industry?

Sustainability

What is your plan to build a more sustainable business practice in the coming years?

Unmet Needs

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

Industry Challenges

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Capacity Expansion

PCI Pharma Services Announces Major Manufacturing Expansion with $100 Million Investment in New England, Providing Global Capacity to Clients

Leadership

Q: What’s the key to being a leader in the industry?

Milestones

Q: What important company milestone do you anticipate reaching in 2022?

Personalized and Precision Medicine

Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?

Therapeutic Progress

Q: For what therapeutic area do you think we will see the greatest progress in the coming years?

Biologics

An Evolving Biologics Landscape and Driving Innovation and Opportunity

Oncology Clinical Trials

Delivering the Full Value Chain for Oncology Clinical Trials

Digital Transformation

Seamlessly Sharing Supply Chain Information to Deliver Measurable Efficiencies for Clients

M&A

Kohlberg and Mubadala Sign a Definitive Agreement to Acquire Majority Stake in PCI Pharma Services

Digitization

The Power of Digital Transformation

Packaging

Advanced, Flexible Packaging Solutions to Meet Parenteral Product Demand